
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Touchlight is an innovation-driven leading CDMO pioneering enzymatic DNA production to enable the genetic medicine revolution. As pioneers with an FDA Drug Master Filing already accepted in 2022, our enzymatic DNA technology is on the cutting edge of AAV, mRNA, DNA vaccine, and in vivo gene editing innovation. With multiple client products already in the clinic, our evidence-based, data-supported synthetic DNA manufacturing solutions offer a scalable, sustainable alternative to plasmid DNA (pDNA) for all stages of pre-clinical, clinical and commercial development. Our company and technology are built on the conviction that DNA is fundamental to the future of medicine. Traditional...
Genetic medicine,dna therapeutics,dna vaccines,enzymatic technology,contract manufacturing,oncology,aav,mrna,cdmo,synthetic dna,lentivirus,gene therapy,dna,genome editing,biotechnology,life science,plasmids,advanced therapies,pharma,and cell therapy
Touchlight operates in the Biotechnology research industry.
Touchlight's revenue is 11m - 100m
Touchlight has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.